These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4087036)

  • 1. Potential role of polyribonucleotides in human neoplastic diseases.
    Borden EC; Verma AK; Wolberg WH
    J Biol Response Mod; 1985 Dec; 4(6):676-9. PubMed ID: 4087036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiviral properties of polynucleotides not associated with interferon induction].
    Shved AD
    Mikrobiol Zh (1978); 1982; 44(3):75-85. PubMed ID: 6181384
    [No Abstract]   [Full Text] [Related]  

  • 3. [Outlook on the use of interferon and its inducers in preventing influenza].
    Ershov FI; Moshchik KV
    Vopr Virusol; 1985; 30(4):388-93. PubMed ID: 2414924
    [No Abstract]   [Full Text] [Related]  

  • 4. [Protective action of double-stranded complexes--interferon inducers in encephalomyocarditis in mice].
    Nosik NN; Lavrukhina LA; Ershov FI
    Biull Eksp Biol Med; 1984 Apr; 97(4):446-8. PubMed ID: 6326886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nonspecific immunotherapy of ophthalmic herpes].
    Kasparov AA; Voĭtsekhovskaia AA; Fadeeva LL; Ul'ianopva TIu; Khavinson VKh
    Vestn Oftalmol; 1986; 102(3):44-7. PubMed ID: 2425474
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor action of pyran copolymer and tilorone against Lewis lung carcinoma and B-16 melanoma.
    Morahan PS; Munson JA; Baird LG; Kaplan AM; Regelson W
    Cancer Res; 1974 Mar; 34(3):506-11. PubMed ID: 4812258
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1988; 10():434-59. PubMed ID: 3079394
    [No Abstract]   [Full Text] [Related]  

  • 8. [Perspectives on interferon research and on its therapeutic use].
    Montagnier L
    Arch Inst Pasteur Tunis; 1981; 58(3):297-312. PubMed ID: 6172080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin in combination therapy for metastatic breast cancer.
    Perez EA
    Oncologist; 2004; 9(5):518-27. PubMed ID: 15477636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferon--the prospects and problems of its use in therapeutic and oncological practice].
    Poverennyĭ AM
    Med Radiol (Mosk); 1983 Jun; 28(6):67-71. PubMed ID: 6191171
    [No Abstract]   [Full Text] [Related]  

  • 11. Polyribonucleotides for cancer therapy: summary and recommendations for further research.
    Herberman RB; Pinsky CM
    J Biol Response Mod; 1985 Dec; 4(6):680-4. PubMed ID: 4087037
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
    Wu Y; Zhong Z; Huber J; Bassi R; Finnerty B; Corcoran E; Li H; Navarro E; Balderes P; Jimenez X; Koo H; Mangalampalli VR; Ludwig DL; Tonra JR; Hicklin DJ
    Clin Cancer Res; 2006 Nov; 12(21):6573-84. PubMed ID: 17085673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferon-inducing and protective action of polyguacyl in an experimental influenza infection].
    Obrosova-Serova NP; Fomina AN; Slepushkin AN; Grushinskaia IA; Balashov VI
    Vopr Virusol; 1981; (4):423-8. PubMed ID: 6171099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical studies with mismatched double-stranded RNA.
    Strayer DR; Carter WA; Brodsky I; Gillespie DH; Greene JJ; Ts'o PO
    Tex Rep Biol Med; 1981-1982; 41():663-71. PubMed ID: 6963499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of a new approach to the pathogenetic therapy of oncological patients].
    Mkrtchian LN; Shukurian SG; Kamalian LA; Aleksanian KA; Ambartsumian AM
    Eksp Onkol; 1990; 12(1):13-5. PubMed ID: 1688762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
    Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
    Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology evaluation: CpG-7909, Coley.
    Paul S
    Curr Opin Mol Ther; 2003 Oct; 5(5):553-9. PubMed ID: 14601526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of approaches to viral chemotherapy.
    Gordon M; Buchanan RL; Crenshaw RR; Kerridge KA; MacNintch JE; Siminoff P
    J Med; 1981; 12(5):289-382. PubMed ID: 6171603
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferons and interferon inducers in cancer treatment.
    Krown SE
    Semin Oncol; 1986 Jun; 13(2):207-17. PubMed ID: 2424089
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vaccine and poludan in experimental and clinical herpes simplex].
    Semenova TB; Selezneva AIu; Fadeeva LL; Barinskiĭ IF
    Vestn Dermatol Venerol; 1984 Nov; (11):24-7. PubMed ID: 6099018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.